Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration
2022 · Brain · 216 citations
https://doi.org/10.1093/brain/awac407
P
Przemysław R. Kac
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
53
Papers
1.4K
Citations
17
h-index
22
i10-index
Przemysław R. Kac is an academic researcher from University of Gothenburg. The author has contributed to research in topics: Dementia and Cognitive Impairment Research & Alzheimer's disease research and treatments & Neuroinflammation and Neurodegeneration Mechanisms. The author has an h-index of 17, co-authored 46 publications.
ORCID: 0000-0001-5083-0924Papers by this author
worksPlasma and CSF biomarkers in a memory clinic: Head‐to‐head comparison of phosphorylated tau immunoassays
2022 · Alzheimer s & Dementia · 209 citations
https://doi.org/10.1002/alz.12841
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
2023 · Molecular Neurodegeneration · 203 citations
https://doi.org/10.1186/s13024-023-00605-8
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease
2024 · Nature Communications · 71 citations
https://doi.org/10.1038/s41467-024-47286-5
Phospho-tau serine-262 and serine-356 as biomarkers of pre-tangle soluble tau assemblies in Alzheimer’s disease
2025 · Nature Medicine · 46 citations
https://doi.org/10.1038/s41591-024-03400-0
The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho‐tau Round Robin study
2025 · Alzheimer s & Dementia · 42 citations
https://doi.org/10.1002/alz.14508
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat